ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics SoftwareGlobeNewsWire • 07/05/23
PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEPGlobeNewsWire • 06/08/23
ResMed Announces Participation in the Goldman Sachs 44th Annual Global Healthcare ConferenceGlobeNewsWire • 06/05/23
3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023GlobeNewsWire • 05/25/23
ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality OfficerGlobeNewsWire • 05/02/23
Sleep-Apnea Growth Stock Breaks Out On Record Earnings; Device Sales SurgeInvestors Business Daily • 05/01/23
ResMed Announces Participation in the 2023 KeyBanc Life Sciences & MedTech Investor ForumGlobeNewsWire • 03/15/23
ResMed's Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of SleepGlobeNewsWire • 03/13/23
ResMed Announces Participation in the Oppenheimer 33rd Annual Healthcare ConferenceGlobeNewsWire • 03/07/23